| Type of Genetic Medicine | How It Works | Example / Use |
|---|
| Gene therapy | Adds, replaces, or modifies a gene to treat disease | Inherited genetic disorders |
| Gene editing | Precisely changes selected DNA sequences | CRISPR-based therapies |
| mRNA medicine | Provides temporary genetic instructions to make a protein | mRNA vaccines, protein replacement approaches |
| siRNA therapy | Silences specific messenger RNA to reduce harmful protein production | Certain rare genetic and metabolic diseases |
| Antisense oligonucleotide therapy | Binds to RNA to modify gene expression or splicing | Spinal muscular atrophy-related therapies |
| CAR-T cell therapy | Genetically modifies immune cells to attack cancer | Blood cancers |
| Carrier / Delivery System | What It Carries | Important Feature |
|---|
| Adeno-associated virus vector | DNA/gene cassette | Commonly used in gene therapy; relatively low pathogenicity |
| Lentiviral vector | Genetic material for stable integration | Used in some cell therapies |
| Adenoviral vector | Genetic instructions | Strong immune response; used in some vaccines and therapies |
| Lipid nanoparticles | mRNA, siRNA, RNA molecules | Non-viral delivery system; important in mRNA vaccines |
| Ex vivo delivery | Modified cells outside the body | Used in CAR-T and some blood disorder therapies |
| In vivo delivery | Genetic medicine delivered directly into the body | Used for targeting organs such as liver, eye, or muscle |
| Delivery System | Type | What It Carries | Important Point |
|---|
| Adeno-associated virus vector | Viral vector | DNA / gene cassette | Common in gene therapy; relatively low pathogenicity |
| Lentiviral vector | Viral vector | Genetic material | Can integrate into host-cell genome; used in some cell therapies |
| Adenoviral vector | Viral vector | Genetic instructions | Can trigger strong immune response |
| Lipid nanoparticles | Non-viral carrier | mRNA, siRNA or other RNA molecules | Widely used in mRNA vaccines and RNA therapies |
| Polymer nanoparticles | Non-viral carrier | DNA or RNA molecules | Being explored for targeted delivery |
| Ex vivo modified cells | Cell-based delivery | Genetically modified patient or donor cells | Used in CAR-T and some gene therapies |
| In vivo direct delivery | Direct body delivery | Genetic material into target tissues | Used for liver, eye, muscle and blood-related targets |
| Basis | Genetic Medicine | Conventional Medicine |
|---|
| Target | Gene, RNA, or genetic pathway | Protein, enzyme, receptor, pathogen, or symptom |
| Mechanism | Corrects, compensates, silences, or modifies genetic expression | Blocks, stimulates, replaces, or suppresses biological activity |
| Duration | May be long-lasting or temporary depending on technology | Usually requires repeated dosing |
| Examples | Gene therapy, mRNA therapy, siRNA therapy, CRISPR therapy | Antibiotics, painkillers, antihypertensives |
| Precision | Often highly targeted | May be broad or targeted depending on drug |
| Genome-wide alteration? | No | Not applicable |
| Point | Explanation |
|---|
| Genetic medicines target faulty genes or gene expression | They may correct, replace, silence, or compensate for disease-causing genetic defects. |
| Vectors are important | Engineered viruses and lipid nanoparticles are common delivery systems. |
| They do not alter the entire DNA sequence | They are targeted therapies and may not even permanently alter DNA. |
| mRNA and siRNA medicines are temporary | They work mainly through RNA and do not change the genome. |
| Gene editing is precise | Technologies like CRISPR aim at selected DNA sequences, not the entire genome. |
| Point | Explanation |
|---|
| Genetic medicine is targeted | It acts on specific genes, RNA molecules or gene-expression pathways. |
| It does not rewrite the whole genome | The statement that genetic medicines alter the entire DNA sequence is incorrect. |
| Delivery system is crucial | Viral vectors and lipid nanoparticles help carry genetic material into cells. |
| RNA-based medicines are usually temporary | mRNA and siRNA therapies generally do not alter DNA. |
| Gene editing is precise but not risk-free | It targets selected DNA regions but may raise concerns about off-target effects. |
| Genetic medicine is broader than gene editing | It includes gene therapy, RNA therapy, cell therapy and other gene-based approaches. |
| Feature | Details |
|---|
| Meaning | Medical treatment using genes, genetic material, RNA, or gene-modifying tools |
| Main purpose | To correct, replace, compensate for, silence, or modify faulty genetic information |
| Target | Specific gene, RNA, mutation, or gene-expression pathway |
| Does it alter entire DNA? | No |
| Possible duration | Temporary or long-lasting, depending on the method |
| Main fields of use | Rare genetic diseases, cancers, metabolic disorders, neurological disorders, immune disorders |
| Important delivery systems | Engineered viruses, lipid nanoparticles, modified cells |
| Major concern | Safety, immune response, off-target effects, cost and ethical issues |
| Type | How It Works | Does It Change DNA? | Example / Use |
|---|
| Gene therapy | Adds or replaces a functional gene | Sometimes, depending on method | Inherited genetic disorders |
| Gene editing | Makes targeted changes in selected DNA sequences | Yes, but only at specific sites | CRISPR-based therapies |
| mRNA medicine | Provides temporary instructions to make a protein | No | mRNA vaccines, protein replacement approaches |
| siRNA therapy | Silences specific messenger RNA | No | Some metabolic and rare diseases |
| Antisense oligonucleotide therapy | Alters RNA processing or blocks harmful RNA activity | No | Spinal muscular atrophy-related therapy |
| CAR-T cell therapy | Genetically modifies immune cells outside the body | Yes, in modified immune cells | Certain blood cancers |
| DNA vaccine | Delivers DNA instructions to produce antigen | Usually does not alter host genome | Some vaccine platforms |
| Basis | Viral Vector | Lipid Nanoparticle |
|---|
| Nature | Engineered virus | Fat-like particle |
| Main role | Delivers genetic material into cells | Delivers RNA or other genetic material into cells |
| Commonly carries | DNA or gene cassette | mRNA, siRNA, RNA molecules |
| Duration of effect | Can be long-lasting | Usually temporary |
| Immune response risk | Possible immune reaction against viral vector | Possible inflammatory reaction, but generally non-viral |
| Genome integration | Some vectors may integrate; others usually do not | Does not integrate into genome |
| Example use | Gene therapy, CAR-T cell engineering | mRNA vaccines, RNA medicines |
| Term | Meaning | Purpose | Example |
|---|
| Genetic medicine | Broad category using genetic material or gene-based mechanisms for treatment | Treat or prevent disease | Gene therapy, mRNA therapy, siRNA therapy |
| Gene therapy | Adds, replaces, or modifies a gene | Correct or compensate for faulty gene function | Functional gene delivery |
| Gene editing | Precisely changes selected DNA sequences | Correct specific mutation or disable harmful gene | CRISPR-Cas systems |
| Genetic testing | Analyses DNA, chromosomes or genes | Diagnose risk, carrier status or disease | BRCA testing, prenatal genetic tests |
| Genomics | Study of the whole genome | Understand genes and their interactions | Population genomics, disease genomics |
| Pharmacogenomics | Studies how genes affect drug response | Personalised medicine | Choosing drug/dose based on genetic profile |
| Statement / Theme | Correct Understanding | Common Trap |
|---|
| Genetic medicines correct or compensate for faulty genes | Correct | Assuming they only replace genes |
| Engineered viruses are used as carriers | Correct | Thinking all viruses are harmful and cannot be used medically |
| Lipid nanoparticles are used as carriers | Correct | Associating them only with vaccines |
| Genetic medicines alter entire DNA sequence | Incorrect | They target specific genes, RNA or pathways |
| mRNA medicines alter DNA | Incorrect | mRNA works in cytoplasm and is temporary |
| Gene editing changes selected DNA sites | Correct | Thinking it rewrites the whole genome |
| REDD+ and genetic medicine | Unrelated concepts | Confusing “gene” with “green” or climate terms in interdisciplinary questions |
| Genetic testing is treatment | Incorrect | Genetic testing is diagnostic, not therapy |